These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11890558)

  • 1. Bacterial persistence within erythrocytes: a unique pathogenic strategy of Bartonella spp.
    Seubert A; Schulein R; Dehio C
    Int J Med Microbiol; 2002 Feb; 291(6-7):555-60. PubMed ID: 11890558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and cellular basis of bartonella pathogenesis.
    Dehio C
    Annu Rev Microbiol; 2004; 58():365-90. PubMed ID: 15487942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bartonella interactions with endothelial cells and erythrocytes.
    Dehio C
    Trends Microbiol; 2001 Jun; 9(6):279-85. PubMed ID: 11390243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasion and persistent intracellular colonization of erythrocytes. A unique parasitic strategy of the emerging pathogen Bartonella.
    Schülein R; Seubert A; Gille C; Lanz C; Hansmann Y; Piémont Y; Dehio C
    J Exp Med; 2001 May; 193(9):1077-86. PubMed ID: 11342592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The VirB/VirD4 type IV secretion system of Bartonella is essential for establishing intraerythrocytic infection.
    Schulein R; Dehio C
    Mol Microbiol; 2002 Nov; 46(4):1053-67. PubMed ID: 12421311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Trw type IV secretion system of Bartonella mediates host-specific adhesion to erythrocytes.
    Vayssier-Taussat M; Le Rhun D; Deng HK; Biville F; Cescau S; Danchin A; Marignac G; Lenaour E; Boulouis HJ; Mavris M; Arnaud L; Yang H; Wang J; Quebatte M; Engel P; Saenz H; Dehio C
    PLoS Pathog; 2010 Jun; 6(6):e1000946. PubMed ID: 20548954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesins of Bartonella spp.
    O'Rourke F; Schmidgen T; Kaiser PO; Linke D; Kempf VA
    Adv Exp Med Biol; 2011; 715():51-70. PubMed ID: 21557057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pestilence, persistence and pathogenicity: infection strategies of Bartonella.
    Minnick MF; Battisti JM
    Future Microbiol; 2009 Aug; 4(6):743-58. PubMed ID: 19659429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of distinct type-IV-secretion systems and secreted effector sets in host adaptation by pathogenic Bartonella species.
    Wagner A; Dehio C
    Cell Microbiol; 2019 Mar; 21(3):e13004. PubMed ID: 30644157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection-associated type IV secretion systems of Bartonella and their diverse roles in host cell interaction.
    Dehio C
    Cell Microbiol; 2008 Aug; 10(8):1591-8. PubMed ID: 18489724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bartonella entry mechanisms into mammalian host cells.
    Eicher SC; Dehio C
    Cell Microbiol; 2012 Aug; 14(8):1166-73. PubMed ID: 22519749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bartonella henselae trimeric autotransporter adhesin BadA expression interferes with effector translocation by the VirB/D4 type IV secretion system.
    Lu YY; Franz B; Truttmann MC; Riess T; Gay-Fraret J; Faustmann M; Kempf VA; Dehio C
    Cell Microbiol; 2013 May; 15(5):759-78. PubMed ID: 23163798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bartonella-host-cell interactions and vascular tumour formation.
    Dehio C
    Nat Rev Microbiol; 2005 Aug; 3(8):621-31. PubMed ID: 16064054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bartonella spp. as a zoonotic pathogens transmitting by blood-feeding arthropods].
    Adamska M
    Wiad Parazytol; 2010; 56(1):1-9. PubMed ID: 20450002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What do we (not) know about the human bartonelloses?
    Velho PE; Cintra ML; Uthida-Tanaka AM; de Moraes AM; Mariotto A
    Braz J Infect Dis; 2003 Feb; 7(1):1-6. PubMed ID: 12807686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion and host cell modulation: critical pathogenicity determinants of Bartonella henselae.
    Franz B; Kempf VA
    Parasit Vectors; 2011 Apr; 4():54. PubMed ID: 21489243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanisms of
    Deng H; Pang Q; Zhao B; Vayssier-Taussat M
    Front Cell Infect Microbiol; 2018; 8():431. PubMed ID: 30619777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bartonella henselae, B. quintana, and B. bacilliformis: historical pathogens of emerging significance.
    Karem KL; Paddock CD; Regnery RL
    Microbes Infect; 2000 Aug; 2(10):1193-205. PubMed ID: 11008109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity and treatment of Bartonella infections.
    Angelakis E; Raoult D
    Int J Antimicrob Agents; 2014 Jul; 44(1):16-25. PubMed ID: 24933445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The VirB type IV secretion system of Bartonella henselae mediates invasion, proinflammatory activation and antiapoptotic protection of endothelial cells.
    Schmid MC; Schulein R; Dehio M; Denecker G; Carena I; Dehio C
    Mol Microbiol; 2004 Apr; 52(1):81-92. PubMed ID: 15049812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.